Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis

Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis

Background: It is unclear whether continuing anti-fibrotic therapy until the time of lung transplant increases the risk of complications in patients with idiopathic pulmonary fibrosis. Objectives: To investigate whether the time between discontinuation of anti-fibrotic therapy and lung transplant in...

Full description

Bibliographic Details
Main Authors: Todd L. Astor, Hilary J. Goldberg, Laurie D. Snyder, Andrew Courtwright, Ramsey Hachem, Tahuanty Pena, Lorenzo Zaffiri, Gerard J. Criner, Marie M. Budev, Tany Thaniyavarn, Thomas B. Leonard, Shaun Bender, Aliaa Barakat, Janis L. Breeze, Peter LaCamera
Format: Article
Language:English
Published: SAGE Publishing 2023-04-01
Series:Therapeutic Advances in Respiratory Disease
Online Access:https://doi.org/10.1177/17534666231165912

Internet

https://doi.org/10.1177/17534666231165912

Similar Items